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ABSTRACT 
It is known that humoral factors of immunity play an important function of 
mediators in the cascade development of the immune response and can 
determine the effectiveness of the final, effector reactions of cellular immunity 
in the inactivation and elimination of antigens. Serum concentrations of major 
immunoglobulins IgG, IgA, IgM in NHL were analyzed. The highest serum 
content of IgG and IgA was revealed in the groups of patients with virus 
carrier. It has been established that one of the most important humoral markers 
of immunity is the circulating immune complexes (CIC). It has been 
established that one of the most important biological functions of 
immunoglobulins is antigen binding and the formation of CIC. A high level of 
CIC in NHL may be due not only to the activation of the immune response, but 
also to the suppression of the mechanisms of their elimination. Therefore, 
based on the results obtained, with NHL there is a pronounced imbalance of 
humoral immunity. CIC of large and small sizes are also increased, however, 
the highest increase in CIC was observed in groups of patients before 
chemotherapy with virus-bearing. An increase in the main immunoglobulins 
indicates the presence of humoral imbalance, and an increase in the CIC 
indicates the presence of intoxication of the body either due to the decay of the 
tumor cells themselves and infected cells, which almost always indicates the 
progression of the pathological process. 
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Despite a significant deepening in the last decade of ideas in the etiology, immunopathogenesis, 
course and progression of malignant processes, many questions regarding the mechanisms of the 
development of the pathological process and its course, evaluation of treatment effectiveness, remain open 
[10,12]. Moreover, in recent years, many etiopathogenetic factors, such as viruses, which have a pronounced 
carcinogenic factor, have been understood. So, an important role in the course and effectiveness of therapy 
for lymphomas belongs to the cellular and humoral factors of the immune system [4,7]. 
At present, great attention is paid to the study of immunological mechanisms in the 
development and progression of lymphomas. An important issue remains the immunodiagnostics of 
cellular and humoral immunity. As the literature shows, publications devoted to the study of immunity 
are sporadic. Basically, articles are devoted to clinical study and the description of the results of 
treatment methods, while there are no works of a pathogenetic nature. Reliable data can only be 
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obtained by analyzing a sufficiently large amount of clinical material that makes it possible to study 
the frequency of occurrence of various NHL variants; comparison of clinical, morphological and 
immunological data, as well as the results of treatment of T- and B-cell lymphomas, which opens up 
the possibility of improving the diagnosis and individualization of chemotherapy programs depending 
on the immunophenotypic characteristics of tumor cells [1,3,8,12]. 
Based on the foregoing, we evaluated the humoral factors of the immune system in patients 
with NHL depending on the virus carrier. 
Purpose of the study. To study the main humoral parameters of immunity in patients with non-
Hodgkin's lymphomas in order to understand the etiopathogenetic features of the course of the disease. 
Materials and research methods. In our study, patients with non-Hodgkin’s lymphomas (NHL) 
were divided into 2 groups: group I - patients with established virus carriers; group II - patients in the 
control group with no virus carrier. In the distribution of NHL patients by age, it was found that virus 
carriage leads to a rejuvenation of the disease: the peak incidence rate in group I is up to 30 years, while the 
same indicator for group II is over 50 years. In sick men with virus carriers, the average age was 35.6 ± 
4.56 years, among women - 27.2 ± 5.24 years, in the control group, the average age of men was 60.7 ± 3.80 
years, women - 45.5 ± 6.97 years. The proportion of women in group I was 21.7 ± 6.44%, men - 78.3 ± 
6.44%; in group II, women accounted for 44.4 ± 7.75%, men - 55.6 ± 7.75%. 
In all patients, the diagnosis was established on the basis of data and the results of a 
comprehensive study (clinical, biochemical, radiological, ultrasound, CT, myelogram, morphological). 
The lesion zones for non-Hodgkin lymphomas in patients with viral infection (group I) most 
often occurred in the neck and axillary lymph nodes (more than 50%), then in the mediastinal, 
supraclavicular, retroperitoneal and inguinal (25-45%), the least significant was the defeat of the iliac l 
/ nodes, spleen, Valdeyer (20% or less). 
In control group II, the picture of lymph node lesions differed from the experimental group — 
patients with affected cervical l / nodes were more than 70%, while the remaining lesion zones were less 
common: axillary, supraclavicular, inguinal l / nodes malignantly transformed in 30-40% of cases; 
mediastinal, retroperitoneal, iliac - in less than 20% of cases; Valdeyer ring damage was observed in more 
than 60% of patients. Viral infection changes the picture of lymph node damage in patients with NHL in 
comparison with patients without viral load: in group I, axillary, mediastinal, supraclavicular, 
retroperitoneal, and inguinal l / nodes were transformed malignantly (25-45%). Group I patients were most 
often infected with HSV herpes simplex virus and Epstein-Barr virus (65-80%). Cytomegalovirus infection 
(CMV), human papilloma virus (HPV) in 43.4 ± 7.7% of patients, and Varicella-Zoster virus were found in 
26.0 ± 6.8% and 8.6 ± 4.4%, respectively. The examination included patients undergoing examination in 
the chemotherapy department. All patients underwent clinical and laboratory blood tests, which included 
the study of a general analysis of blood and urine, biochemical and immunological parameters, as well as 
the blood coagulation system. Patients underwent a comprehensive clinical and instrumental examination 
aimed at clarifying the prevalence of the tumor process and identifying existing complications. 
Immunological studies included the study of the humoral parameters of the immune system of 
patients. The humoral immunity parameters were determined by studying the main immunoglobulins 
A, M, G using commercial test systems for enzyme-linked immunosorbent assay produced by 
"Human", Germany. 
When conducting a statistical analysis of the data presented in the work, the results of the 
study were entered into databases prepared in the Microsoft Excel XP program. Numerical 
(continuous) values were presented as arithmetic means and mean errors (M ± m). Comparison of 
quantitative characteristics was carried out using Student's criterion, for continuous variables - paired 
Student's criterion. P <0.05 was taken as a boundary comparative criterion of statistical significance. 
The obtained research results and their discussion. 
It has been established that the functional usefulness of B-lymphocytes in the immune 
response is characterized by the production of immunoglobulins [10,12]. It is known that 
immunoglobulins play an important function of mediators in the cascade development of the immune 
response and can partly determine the effectiveness of the final, effector responses of cellular 
immunity in the inactivation and elimination of antigens [7,8]. It is also known that circulating 
antibodies are one of the effector factors of immunity, which provides antigen-specific protection 
[1,3,4,8]. We have analyzed the serum concentrations of the main immunoglobulins IgG, IgA, IgM in 
NHL. As can be seen from the data presented, the content of the main serum immunoglobulins varied 
widely. The highest serum IgG content was detected in the group of patients before treatment without 
virus carrier, and the lowest content was noted in the group of patients with virus carrier, that is, due to 
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a factor that suppresses immunity. The serum IgM content in almost all groups of patients with NHL 
was within the normative values, and there were no specific deviations between the groups of patients. 
Thus, the serum IgG content in the group of patients before treatment with virus-bearing was 1374.5 ± 
46.4 mg%, in the group of patients without virus-bearing - 1287.9 ± 56.8 mg%, with a standard value 
of 1148.5 ± 35.6 mg%. Analysis of IgA content revealed the presence of a significant increase in 
serum IgA in all groups of patients with NHL. Moreover, the highest content was noted in the group of 
patients with virus carrier. Consequently, the humoral immunity was characterized by an increase in 
serum concentrations of IgG and IgA in groups of patients with NHL. 
One of the most important humoral markers of immunity is the circulating immune complexes 
(CICs). It has been established that one of the most important biological functions of immunoglobulins is 
antigen binding and the formation of CICs [6,12]. An important characteristic of the CIC is their size, which 
can be large and small. The analysis showed that the CIC of large and small sizes in all groups of patients 
were significantly increased. So, the CIC of large quantities were significantly increased before treatment. 
As for the CIC of small quantities, a significant increased content is also observed. The highest average 
value of small CIC was revealed in groups of patients before treatment and after treatment without 
immunotherapy. Apparently, this is due to the lack of necessary detoxification and effects on the functioning 
of the immune system. Also, a CIC of 4% of small values are observed, the smallest value close to normal in 
the group of patients without virus carrier. It is known that CIC3% of large quantities formed with an excess 
of antibodies, although they are able to bind complement, are large, insoluble, quickly phagocytized and 
have low pathogenicity [2,3,5]. The greatest pathological potential is possessed by soluble immune 
complexes of small sizes, which were formed with an excess of antigen [4,7]. A high level of CIC can be 
caused not only by activation of the immune response, but also by suppression of the mechanisms of their 
elimination [2,6,10,11]. The latter, apparently, is associated with a weakening of the function of the cells of 
the monocyte-macrophage system - cells that absorb and disintegrate the immune complexes. Therefore, 
activation of the humoral immunity is observed along with severe depression of the cellular immunity. 
Thus, based on the results obtained, it is seen that with NHL there is a pronounced imbalance 
of humoral immunity. CIC of large and small sizes are also increased, however, the largest increase in 
CIC was observed in groups of patients prior to chemotherapy with virus-bearing compared with data 
from patients without virus-bearing. An increase in major immunoglobulins indicates the presence of 
humoral imbalance, and an increase in CIC indicates intoxication of the body either due to the decay 
of the tumor cells themselves and infected cells. An increase in CIC of 4% always indicates the 
progression of the pathological process and is a marker of the progression or worsening of the clinical 
course. CIC3% quickly disintegrate in the body, so they have no pathological potential. 
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